The expression of PD-L1 (Ventana SP142) in HER2-positive breast cancer and its relationship with clinicopathological characteristics

被引：0
|
作者：
Zhang, Ningning [1 ]
Liu, Yueping [1 ]
机构：
[1] Hebei Med Univ, Hosp 4, Dept Pathol, Shijiazhuang, Hebei, Peoples R China
来源：
CANCER RESEARCH | 2021年 / 81卷 / 04期
关键词：
breast cancer; HER2-positive; PD-L1; TILs;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS2-30
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Development of a PD-L1 companion diagnostic IHC assay (SP142) for atezolizumab
    Boyd, Zachary S.
    Smith, Dustin
    Baker, Brian
    Vennapusa, Bharathi
    Koeppen, Hartmut
    Kowanetz, Marcin
    Mariathasan, Sanjeev
    Bruey, Jean-Marie
    Mackey, Howard
    Fine, Gregg
    Mocci, Simonetta
    Hegde, Priti
    Williams, J. Andrew
    McCaffery, Ian
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [42] PD-L1 expression and CD8-positive T cells are associated with favorable survival in HER2-positive invasive breast cancer
    Hou, Yanjun
    Nitta, Hiroaki
    Wei, Lai
    Banks, Peter M.
    Lustberg, Maryam
    Wesolowski, Robert
    Ramaswamy, Bhuvaneswari
    Parwani, Anil V.
    Li, Zaibo
    BREAST JOURNAL, 2018, 24 (06): : 911 - 919
  • [43] PD-L1 expression and presence of ICs in HER2-positive breast carcinoma before and after neoadjuvant treatment
    Bogosavljevic, M.
    Kapic, T. Ivkovic
    Vasiljevic, T.
    Stanulovic, N.
    VIRCHOWS ARCHIV, 2024, 485 : S51 - S52
  • [44] Relationship between SP142 PD-L1 Expression and 18F-FDG Uptake in Non-Small-Cell Lung Cancer
    Zhao, Long
    Liu, Jinjun
    Shi, Jingyun
    Wang, Huoqiang
    CONTRAST MEDIA & MOLECULAR IMAGING, 2020, 2020
  • [45] PD-L1 expression in tumor infiltrating lymphocytes (TILs) inversely correlates with androgen receptor (AR) expression in HER2-positive breast cancer
    Shen, Tiansheng
    Pincus, Jennifer L.
    Siziopikou, Kalliopi P.
    CANCER RESEARCH, 2020, 80 (04)
  • [46] Programmed death-ligand 1 (PD-L1) expression in tumour cell and tumour infiltrating lymphocytes of HER2-positive breast cancer and its prognostic value
    Ahrong Kim
    So Jeong Lee
    Young Keum Kim
    Won Young Park
    Do Youn Park
    Jee Yeon Kim
    Chang Hun Lee
    Gyungyub Gong
    Gi Yeong Huh
    Kyung Un Choi
    Scientific Reports, 7
  • [47] Programmed death-ligand 1 (PD-L1) expression in tumour cell and tumour infiltrating lymphocytes of HER2-positive breast cancer and its prognostic value
    Kim, Ahrong
    Lee, So Jeong
    Kim, Young Keum
    Park, Won Young
    Park, Do Youn
    Kim, Jee Yeon
    Lee, Chang Hun
    Gong, Gyungyub
    Huh, Gi Yeong
    Choi, Kyung Un
    SCIENTIFIC REPORTS, 2017, 7
  • [48] PD-L1 expression and the prognostic significance in gastric cancer: a retrospective comparison of three PD-L1 antibody clones (SP142, 28–8 and E1L3N)
    Jing Ma
    Jianhui Li
    Meirui Qian
    Weili Han
    Miaomiao Tian
    Zengshan Li
    Zhe Wang
    Shuixiang He
    Kaichun Wu
    Diagnostic Pathology, 13
  • [49] Correlation between TILs, ALDH1 and PD-L1 expression in triple-negative (TN) and HER2-positive (HER2+) breast cancer (BC)
    Lopez Flores, M.
    Honrado Franco, E.
    Sanchez Couisido, F.
    Minguito Carazo, C.
    Vallejo Pascual, M. E.
    Sanz Guadarrama, O.
    Garcia Palomo, A.
    Molina de la Torre, A. J.
    Lopez Gonzalez, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S437 - S438
  • [50] Correlation of PD-L1 SP142 Immune Cell Positivity with Tumor Mutational Burden and Microsatellite Instability in Triple Negative Breast Cancer
    Brown, C. A.
    Li, X.
    Huang, R. S.
    Severson, E.
    Edgerly, C.
    Duncan, D.
    Hemmerich, A.
    Smith, C.
    Thompson, B.
    Xiao, J.
    Virgilio, J.
    Killian, J. K.
    Ngo, N.
    Lin, D.
    Britt, N.
    Elvin, J.
    Owens, C.
    Miller, V. A.
    Alexander, B.
    Ross, J. S.
    Ramkissoon, S. H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1207 - 1208
12345